Information:
Error:
ID
14835
Description
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT01423032
Link
https://clinicaltrials.gov/show/NCT01423032
Keywords
Versions (1)
- 5/1/16 5/1/16 -
Uploaded on
May 1, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Lymphocytic Leukemia NCT01423032
Eligibility Chronic Lymphocytic Leukemia NCT01423032
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT01423032
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
histologically or immunologically confirmed chronic b-cell leukemia
boolean
C0023434 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,2])
ID.2
Item
refractory (i.e. no response or progression during initial chemotherapy) or relapsed situation after first-line treatment regimen
boolean
C0278791 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0277556 (UMLS CUI [2])
ID.3
Item
disease stage ii-iv according to rai or b/c according to binet staging system, respectively
boolean
C1511118 (UMLS CUI [1])
C1514715 (UMLS CUI [2])
C1514715 (UMLS CUI [2])
ID.4
Item
eastern cooperative oncology group (ecog) performance status of 3 or better
boolean
C1520224 (UMLS CUI [1])
ID.5
Item
negative pregnancy test/ adequate method of contraception
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
ID.6
Item
t-cll, pll (prolymphocytic leukemia)
boolean
ID.7
Item
presence of richter's transformation
boolean
C0349631 (UMLS CUI [1])
ID.8
Item
first-line treatment containing either fludarabine or bendamustine
boolean
C0059985 (UMLS CUI [1])
C0525079 (UMLS CUI [2])
C0525079 (UMLS CUI [2])
ID.9
Item
acute infections or distinctly reduced organ function precluding the application of chemotherapy, as for pulmonary, heart, liver (total bilirubin > 5mg/dl), renal system (creatinine > 2 mg/dl), or metabolic disorders
boolean
C0275518 (UMLS CUI [1])
C0025517 (UMLS CUI [2])
C0678852 (UMLS CUI [3])
C0025517 (UMLS CUI [2])
C0678852 (UMLS CUI [3])
ID.10
Item
secondary malignancy (except for curative treated basal cell carcinoma or cervical cancer)
boolean
C3266877 (UMLS CUI [1])